🇺🇸 FDA
Patent

US 7682607

Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

granted A61PA61P35/00A61P43/00

Quick answer

US patent 7682607 (Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas) held by The Regents of the University of California expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P35/00, A61P43/00